“United we Win”,Communication is the Key for a Better Future in Scleroderma

Rodnan GP Benedek TG An historical account of the study of progressive systemic sclerosis (diffuse scleroderma). Ann Intern Med 1962;57(2_Part_1)305–319

Denton CP Black CM Historical perspective. In VargaJ, Denton CP, Wigley FM Eds. Scleroderma. From pathogenesis to comprehensive management. Springer, 2012;1-689 pp3–6 ISBN: 9781461490272.

Beck JS Anderson JR Gray KG Rowell NR Antinuclear and precipitating autoantibodies in progressive systemic sclerosis. Lancet 1963;2(7319)1188–1190

Moroi Y Peebles C Fritzler MJ Steigerwald J Tan EM Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 1980;77(3)1627–1631

Tan EM Rodnan GP Garcia I Moroi Y Fritzler MJ Peebles C Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum 1980;23(6)617–625

Ross JB Nail fold capillaroscopy—a useful aid in the diagnosis of collagen vascular diseases. J Invest Dermatol 1966;47(4)282–285

Maricq HR LeRoy EC Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 1973;16(5)619–628

Leroy EC Connective tissue synthesis by scleroderma skin ­fibroblasts in cell culture. J Exp Med 1972;135(6)1351–1362

Ludwicka A Trojanowska M Smith EA et al. Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma. J Rheumatol 1992;19(11) 1716–1723

Kirk TZ Mark ME Chua CC Chua BH Mayes MD Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 1995;270(7)3423–3428

Stummvoll GH Aringer M Grisar J et al. Increased transendothelial migration of scleroderma lymphocytes. Ann Rheum Dis 2004;63(5)569–574

Manetti M Guiducci S Ruffo M et al. Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis. J Cell Mol Med 2013;17(4)482–496

Chimen M McGettrick HM Apta B et al. Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory disease. Nat Med 2015;21(5)467–475

Wigerblad G Bas DB Fernades-Cerqueira C et al. Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-­dependent mechanism. Ann Rheum Dis 2015 Nov 27. pii: annrheumdis-2015-208094. [Epub ahead of print].

Krishnamurthy A Joshua V Haj Hensvold A et al. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann Rheum Dis 2015 Nov 26 pii: annrheumdis-2015-208093. [Epub ahead of print].

Vaughan JH Shaw PX Nguyen MD et al. Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. J Rheumatol 2000;273 821–823

Hamamdzic D Kasman LM LeRoy EC The role of infectious agents in the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 2002;14(6)694–698

Mori Y Kahari VM Varga J Scleroderma-like cutaneous syndromes. Curr Rheumatol Rep 2002;4(2)113–122

Wollheim FA Messages from the morgue to rheumatology: from Chagas disease to giant cell arteritis. Arthritis Res Ther 2013;15(6):131

Andreasson K Personal communication 2015.

Frech TM Khanna D Maranian P Frech EJ Sawitzke AD Murtaugh MA Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/distention. Clin Exp Rheumatol 2011;29(2 Suppl 65)S22–S25